If you’ve ever wondered about the vax and it’s EUA usage status, well you’ve come to the right place. This article is from Tracy Beanz website at UncoverDC.
As always she and her crew of journalists put together some of the most extensive and detailed reports I’ve ever seen. EUA, which stands for Emergency Use Authorization, is what the current vaxxes that are being jabbed into people at alarming rates, are administered under. And cannot be licensed until the FDA gives full approval. Anyway, please read their article below and be sure to visit UncoverDC for much more.
The ongoing and unprecedented drive to protect humanity from SARS-CoV-2 using one of the experimental COVID-19 “vaccines” is made possible because of Emergency Use Authorization (EUA). The action allows the Food and Drug Administration (FDA) to authorize formally unapproved products for temporary use as emergency countermeasures against threats to public health and safety. A handful of crucial events led to the enactment of the FDA’s emergency powers, illustrating “how its use today against COVID-19 involves fundamental questions about the role of public officials, scientific expertise, and administrative norms in times of crisis.”
History Leading Up To EUA
Outlining the pre-history of EUA are the Thalidomide disaster in the 1950s; the “swine flu” epidemic in 1976; the AIDS crisis in the late 1980s; and the events of September 11, 2001. Tragically, the decade following the introduction of thalidomide revealed severe birth defects in the tens of thousands, with the catastrophe highlighting the importance of stringent standards of clinical review before the approval of new food and drug products.
The swine flu incident followed, which was ultimately defined as a policymaking disaster with serious health consequences (more on that below). Next, as an early precursor to EUA, the AIDS crisis introduced “DDI,” an investigational drug that was not yet known to be safe and effective. At the time, some argued that the risks of breaking protocol by issuing a new drug paled in comparison to the number of lives it could save. Advocating for experimental testing of the drug was Dr. Anthony Fauci, as described in Harvard’s Bill of Health:
“Impatient with FDA regulators’ conservative approach, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, proposed a new “parallel track” system to administer DDI to eligible patients while continuing to study the drug. Other measures for circumventing FDA’s formal approval process already existed at the time, but this proposal attracted the attention of President George H.W. Bush, whose support encouraged FDA to adopt the process and administer DDI to those in need.”
After 9/11, with the 2004 enactment of the Project Bioshield Act, the “War on Terror” solidified the EUA. The act ordered billions of dollars in appropriations to purchase vaccines in preparation for a bioterror attack, along with the stockpiling of emergency countermeasures. To act rapidly in an emergency, Congress allowed the FDA to authorize formally unapproved products for emergency use against a threat to public health and safety (subject to a declaration of emergency by HHS). The congressional record shows that Congress was focused explicitly on a bioterror threat—not on preparing for a naturally occurring pandemic.
Following its enactment, for sixteen years, the EUA was implemented very little. It was used most extensively in combating the H1N1 swine flu pandemic of 2009 “by authorizing medical equipment and existing influenza drugs.” Bill of Health points out that, following an amendment allowing for preemptive EUAs, the emergency measure was also used to “authorize occasional countermeasures in anticipation of MERS, Ebola, Zika, and other epidemics, none of which ultimately materialized in the United States.”
Leading Up to the Current EUAs Against COVID-19
On January 31, 2020, Alex M. Azar II, then-Secretary of Health and Human Services under President Trump, announced his determination that a public health emergency existed in the United States, declaring:
“As a result of confirmed cases of 2019 Novel Coronavirus (2019-nCoV), on this date and after consultation with public health officials as necessary, I, Alex M. Azar II, Secretary of Health and Human Services, pursuant to the authority vested in me under section 319 of the Public Health Service Act, do hereby determine that a public health emergency exists and has existed since January 27, 2020, nationwide.”
Azar’s announcement came ten days after the CDC confirmed the first case of 2019 Novel Coronavirus (2019-nCoV) in the United States—in the state of Washington—in a patient who had recently returned from Wuhan, China. Describing the virus, the CDC press release added, “While originally thought to be spreading from animal-to-person, there are growing indications that limited person-to-person spread is happening. It’s unclear how easily this virus is spreading between people.”
To date, “Continued Consequences of Coronavirus Disease 2019 (COVID-19) (formerly called 2019 Novel Coronavirus (2019-nCoV)) Pandemic” has prompted DHHS to renew its public health emergency six times. The latest renewal occurred on July 19, 2021, under the leadership of current HHS Secretary Xavier Becerra.
Emergency Use Authorization…
Read full story here: COVID-19: Emergency Use Authorization – UncoverDC